<DOC>
	<DOCNO>NCT02320877</DOCNO>
	<brief_summary>In prospective trial 50 patient , diagnose moderate severe obstructive sleep apnea ( OSA ) ( AHI &gt; 15/h sleep ) include treated mandibular advancement device ( MAD ) . These patient undergo cardiovascular examination ; echocardiography 24h-blood pressure monitoring , top normal clinical evaluation OSA patient . These cardiovascular examination take place MAD therapy .</brief_summary>
	<brief_title>Evaluation Cardiovascular Effects MAS Treatment Obstructive Sleep Apnea</brief_title>
	<detailed_description />
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Methaqualone</mesh_term>
	<criteria>AHI &gt; 15 events/hour No active OSA therapy 3 month precede inclusion Willing participate inform consent Positive advice OAT DISE Insufficient teeth support device Periodontal problem include tooth mobility Active temporomandibular joint dysfunction Limited maximum protrusive capacity ( &lt; 6 mm )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>